CXCR4 expression was low (ranging from 0% to 62.5%, median 2.4%) and CD133 level was even lower (ranging from 0% to 48%, median 1.25%) in the fresh ovarian cancer cells. This evidence concerns the gene CXCR4 and ovarian cancer.